Cargando…

Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor

MELK is upregulated in various types of human cancer and is known to be associated with cancer progression, maintenance of stemness, and poor prognosis. OTS167, a MELK kinase inhibitor, shows potent growth-suppressive effect on human tumors in a xenograft model, but the detailed mode of action has n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Suyoun, Kijima, Kyoko, Kudo, Aiko, Fujisawa, Yoshiko, Harada, Yosuke, Taira, Akiko, Takamatsu, Naofumi, Miyamoto, Takashi, Matsuo, Yo, Nakamura, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951280/ https://www.ncbi.nlm.nih.gov/pubmed/26918358 http://dx.doi.org/10.18632/oncotarget.7685

Ejemplares similares

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)

Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
por: Chung, Suyoun, et al.
Publicado: (2012)

Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2016)

Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
por: Kato, Taigo, et al.
Publicado: (2016)

Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia
por: Alachkar, Houda, et al.
Publicado: (2014)

p53-independent p21 induction by MELK inhibition
por: Matsuda, Tatsuo, et al.
Publicado: (2017)

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX
por: Vougiouklakis, Theodore, et al.
Publicado: (2018)

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
por: Laha, Dipranjan, et al.
Publicado: (2022)

High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
por: Ikeda, Yuji, et al.
Publicado: (2020)

2193: Targeting MELK in acute lymphoblastic leukemia, new therapeutic approach
por: Alachkar, Houda, et al.
Publicado: (2018)

MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2015)

Correction: MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2018)

T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia
por: Alachkar, Houda, et al.
Publicado: (2015)

Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
por: Cigliano, Antonio, et al.
Publicado: (2019)

Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis
por: Takeuchi, Hiroaki, et al.
Publicado: (2017)

MELK—a conserved kinase: functions, signaling, cancer, and controversy
por: Ganguly, Ranjit, et al.
Publicado: (2015)

MELK is a novel therapeutic target in high-risk neuroblastoma
por: Guan, Shan, et al.
Publicado: (2017)

MELK is not necessary for the proliferation of basal-like breast cancer cells
por: Huang, Hai-Tsang, et al.
Publicado: (2017)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
por: Stefka, A T, et al.
Publicado: (2016)

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer
por: Pickard, Mark R, et al.
Publicado: (2009)

MELK expression correlates with tumor mitotic activity but is not required for cancer growth
por: Giuliano, Christopher J, et al.
Publicado: (2018)

Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family
por: Lin, Meng-Lay, et al.
Publicado: (2007)

MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
por: Joshi, Kaushal, et al.
Publicado: (2013)

A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells
por: Wang, Yubao, et al.
Publicado: (2018)

TOPK (T‐LAK cell‐originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
por: Park, Jae‐Hyun, et al.
Publicado: (2017)

Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation
por: Nakano, Ichiro, et al.
Publicado: (2005)

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
por: Wang, Yubao, et al.
Publicado: (2014)

MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway
por: Xu, Qinyang, et al.
Publicado: (2020)

MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors
por: Meel, Michaël H, et al.
Publicado: (2020)

MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
por: Tang, Qin, et al.
Publicado: (2020)

Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer
por: Hardeman, Ashley A., et al.
Publicado: (2022)

Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models
por: Harris, Emily M., et al.
Publicado: (2018)

Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production
por: CHUNG, Suyoun, et al.
Publicado: (2011)

Correction: MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
por: Wang, Yubao, et al.
Publicado: (2018)

Up-regulation of MELK by E2F1 promotes the proliferation in cervical cancer cells
por: Sun, Hongzhi, et al.
Publicado: (2021)

Ectopic expression of MELK in oral squamous cell carcinoma and its correlation with epithelial mesenchymal transition
por: Li, Bo, et al.
Publicado: (2021)

Computational exploration of maternal embryonic leucine zipper kinase (MELK) as a cancer drug target
por: Makki Almansour, Nahlah
Publicado: (2022)

siRNA-Mediated MELK Knockdown Induces Accelerated Wound Healing with Increased Collagen Deposition
por: Szymanski, Lukasz, et al.
Publicado: (2023)

AURKA, TOP2A and MELK are the key genes identified by WGCNA for the pathogenesis of lung adenocarcinoma
por: Xu, Yunqing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n9c2i7uulq3uiuivktog50c0d2